Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cerebroprotective activity of novel free radical scavenger established in animal model

June 9, 1997

Preclinical neuroprotective activity of P&U antioxidants

June 9, 1997

Tachykinin antagonists prepared by Merck & Co.

June 9, 1997

Janssen and Neurocrine Biosciences disclose CRF antagonists

June 9, 1997

COMT inhibitor increases response to L-DOPA in patients with PD

June 6, 1997

Alpha2-antagonist effective in patients with Parkinson's disease

June 6, 1997

Promising animal data reported for Mitsui Toatsu cerebroprotectant

June 6, 1997

Olanzapine superior to haloperidol against negative symptoms in schizophrenia

June 6, 1997

Body weight positively correlated with cognitive performance in AD

June 6, 1997

FDA approves generic version of Diamox

June 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...